USPTO Patent Granted for Remote Medicine and Device Activation

ChangeBridge: Patent Grants - Pharma (A61K)

Published March 24th, 2026

Detected March 25th, 2026

Summary

The USPTO has granted a new patent (US12582839B2) for systems, devices, and methods related to the remote activation of medicines and medical devices. The patent describes techniques for external guidance and activation systems, including magnetically or radiation-activated sub-devices for targeted drug delivery.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582839B2, titled 'Systems, devices and methods for the remote activation of medicines and medical devices.' The patent covers novel techniques for remotely administering medicines and activating medical devices using external guidance and activation systems. Key aspects include energizing medicines or devices to a predetermined threshold by external radiation, driving them to a treatment target, and employing magnetically or radiation-activated sub-devices for precise drug delivery commanded by a control system.

This patent grant is primarily relevant for entities involved in pharmaceutical and medical device research and development. While it does not impose immediate compliance obligations, it signifies innovation in targeted drug delivery and remote medical device activation. Companies in this space should be aware of this patented technology, as it may impact future product development and intellectual property strategies. No specific compliance deadlines or penalties are associated with this patent grant itself.

Source document (simplified)

← USPTO Patent Grants

Systems, devices and methods for the remote activation of medicines and medical devices

Grant US12582839B2 Kind: B2 Mar 24, 2026

Inventors

Christopher V. Beckman

Abstract

New techniques for remote administration of medicine and medical devices using an external guidance and activation system are provided. In some embodiments, medicine(s) and/or medical device(s) is/are energized to a predetermined threshold energy level by externally applied radiation, and then driven into the treatment target. The design of such device(s) (e.g., injectable machine(s)) may include sub-device(s), e.g., medical payload-carrying reservoir(s), injector(s) and abrasive tool(s), which may be activated magnetically and/or by such radiation. In some aspects, such sub-device(s) include actuable housing(s) and/or other sub-tool(s), delivering drugs to specific locations commanded by a control system or a user. In other aspects, a medicine and/or device is provided with multiple dipoles, each oriented differently in three-dimensional space, allowing a guidance control system, remote from the medicine or device, to drive the movement and three-dimensional orientation of the medical agent or particle according to a three-dimensional path.

CPC Classifications

A61N 5/1031 A61N 5/1001 A61N 5/1067 A61N 5/1084 A61N 2005/1094 A61N 2005/1096 A61N 2005/1098 A61K 9/51 A61K 41/0038 G16H 20/40 G16H 40/63 G16H 40/67 B82Y 5/00 A61P 35/00